Table of Contents
1 Table of Contents 3
1.1 List of Tables 8
1.2 List of Figures 9
2
Introduction 10
2.1 What Is This Report About? 10
3 Definitions of the
Markets/Categories Covered 11
3.1 Cardiovascular Devices 11
3.1.1
Cardiac Rhythm Management 11
3.2 Patient monitoring 11
3.2.1 Remote
patient monitoring 11
4 Company Snapshot 12
4.1 Company Overview
12
4.2 Financial Performance 12
4.3 Industry Outlook -- Cardiovascular
Devices 12
5 Business Description 13
5.1 Business Overview 13
5.2
Major Products and Services 14
5.2.1 Overview 14
6 History 15
7
Competitors 17
8 BIOTRONIK GmbH & Co. KG, Medical Equipment Company Share
Anaysis by Market 18
8.1 BIOTRONIK GmbH & Co. KG, Cardiovascular
Devices, Global, Market Share (2007) 18
8.2 BIOTRONIK GmbH & Co. KG,
Cardiovascular Devices, APAC, Market Share (2007) 19
8.3 BIOTRONIK GmbH &
Co. KG, Cardiovascular Devices, Europe, Market Share (2007) 20
8.4
BIOTRONIK GmbH & Co. KG, Cardiovascular Devices, MEA, Market Share (2007)
22
8.5 BIOTRONIK GmbH & Co. KG, Cardiovascular Devices, North America,
Market Share (2007) 23
8.6 BIOTRONIK GmbH & Co. KG, Cardiovascular
Devices, SCA, Market Share (2007) 24
8.7 BIOTRONIK GmbH & Co. KG, Patient
Monitoring, Global, Market Share (2007) 25
8.8 BIOTRONIK GmbH & Co. KG,
Patient Monitoring, Europe, Market Share (2007) 26
8.9 BIOTRONIK GmbH &
Co. KG, Patient Monitoring, North America, Market Share (2007) 27
9
BIOTRONIK GmbH & Co.KG Medical Equipment Company Share Analysis by Category
28
9.1 BIOTRONIK GmbH & Co.KG, Global, Cardiovascular Devices by Category,
Market Share (2007) 28
9.2 BIOTRONIK GmbH & Co.KG, Europe, Cardiovascular
Devices by Category, Market Share (2007) 29
9.3 BIOTRONIK GmbH & Co.KG,
Europe, Cardiovascular Devices by Category, Market Share (2007) 30
9.4
BIOTRONIK GmbH & Co.KG, MEA, Cardiovascular Devices by Category, Market Share
(2007) 32
9.5 BIOTRONIK GmbH & Co.KG, North America, Cardiovascular
Devices by Category, Market Share (2007) 33
9.6 BIOTRONIK GmbH & Co.KG,
SCA, Cardiovascular Devices by Category, Market Share (2007) 34
9.7
BIOTRONIK GmbH & Co.KG, Global, Patient Monitoring by Category, Market Share
(2007) 35
9.8 BIOTRONIK GmbH & Co.KG, Europe, Patient Monitoring by
Category, Market Share (2007) 36
9.9 BIOTRONIK GmbH & Co.KG, North
America, Patient Monitoring by Category, Market Share (2007) 37
10 Key
Employees 38
11 Locations And Subsidiaries 39
11.1 Head Office 39
11.2 Other Locations & Subsidiaries 39
12 Financial Deals Landscape 41
12.1 Acquisition 41
12.1.1 BIOTRONIK Acquires VascoMed 41
12.1.2
Micrus Endovascular And BIOTRONIK Sign Development And Distribution Agreement
42
12.1.3 BIOTRONIK Signs An Agreement With CONOR Medsystems 44
12.1.4
BIOTRONIK Signs An Agreement With GE Healthcare 45
13 Recent Developments
47
13.1 Strategy and Business Planning 47
13.1.1 May 10, 2006:
BIOTRONIK Signs Multi-Drug Agreement With Novartis 47
13.2 Product
Announcements 47
13.2.1 May 26, 2008 BIOTRONIK Launches Corox OTW BP
Lead 47
13.2.2 May 26, 2008 BIOTRONIK Launches Corox OTW S-BP Lead
48
13.2.3 Apr 09, 2008 BIOTRONIK Announces First Implants Of Lumax 540
Series 49
13.2.4 Mar 20, 2008 Biotronik Concludes Enrollment Of Home
Monitoring Trial 50
13.2.5 Feb 22, 2008 BIOTRONIK Home Monitoring For
Patients With Cardiac Devices Launched In India 50
13.2.6 Jan 15, 2008
BIOTRONIK Launches New Endovascular Portfolio For BTK 50
13.2.7 Jan 14,
2008 BIOTRONIK Launches New Peripheral PTA Portfolio 51
13.2.8 Jan 14,
2008 Biotronik Launches New Peripheral PTA Portfolio 51
13.2.9 Jan 08,
2008 Next Generation Cylos 990 Pacemaker Offers Advanced Therapy For
Optimizing Hemodynamics While Streamlining Patient Follow-Up 51
13.2.10
Sep 12, 2007 BIOTRONIK Announces Market Release and First Implantation Of An
Innovative Therapy System For Primary Prevention Of Sudden Cardiac Death
52
13.2.11 Aug 31, 2007 BIOTRONIK Announces CE Approval Of An Innovative
Therapy System For Primary Prevention Of Sudden Cardiac Death 52
13.2.12
Jul 13, 2007 Biotronik Completes Enrollment Of DES Trial 52
13.2.13 Jun
19, 2007 BIOTRONIK Completes Enrollment Of ProLimus I First-In-Man
Pimecrolimus Drug Eluting Stent Trial 53
13.2.14 Jul 28, 2006 BIOTRONIK
Announces First Implantation Of The New ICD Lumax HF-T For Cardiac
Resynchronisation Therapy With Fully Automatic Cardiac Monitoring 53
13.2.15 Apr 10, 2006 BIOTRONIK Announces FDA Approval And First Implant Of
The Linox SD Lead 53
13.2.16 Jan 12, 2006 Market Release Of BIOTRONIK
Pacemaker Featuring A Physiologic Rate-Adaptive Algorithm And Wireless
Transmissions For Arrhythmia Monitoring And Event Notification 54
13.2.17
May 17, 2005 BIOTRONIK Inc, Announces FDA Approval And First US Implant Of
Xelos DR-T Implantable Cardioverter Defibrillator 55
13.2.18 Oct 04, 2004
BIOTRONIK Announces FDA Approval And First US Implants Of The Philos II DR
Pacemaker 55
13.2.19 Sep 19, 2007: BIOTRONIK Wins Cardiac Rhythm
Management Contract 56
13.2.20 Jan 09, 2006: BIOTRONIK Signs Development
And Distribution Agreement With Micrus 56
14 BIOTRONIK GmbH & Co. KG
Pipeline Products 57
14.1 Lumax HF-T 57
14.1.1 Product Overview 57
14.1.2 Product Description 57
14.1.3 Product Status 57
14.1.4 Clinical
Trials 57
14.1.5 Product Milestone 59
14.2 ProGenic
Pimecrolimus-eluting Coronary Stent System 59
14.2.1 Product Overview
59
14.2.2 Product Description 59
14.2.3 Product Status 60
14.2.4
Clinical Trials 60
14.2.5 Product Milestone 61
14.3 Absorbable Metal
Stent (AMS) 61
14.3.1 Product Overview 61
14.3.2 Product Description
61
14.3.3 Product Status 62
14.3.4 Clinical Trials 62
15 Appendix
63
15.1 Global Markets Direct Research Methodology 63
15.2 Coverage
64
15.3 Secondary Research 64
15.4 Primary Research 65
15.5 Models
65
15.6 Forecasts 66
15.7 Expert Panels 66
15.8 Market Revenue
Chapters 66
15.8.1 Abbreviations 66
15.8.2 Currency Conversions 67
15.9 About Global Markets Direct 68
15.10 Contact Us 68
15.11
Disclaimer 68
View Cart
